Once primarily used for blood sugar management, GLP-1 receptor agonists are now recognised for their broader role in protecting the heart, kidneys, and even sleep health, transforming long-term care strategies for patients with type 2 diabetes and obesity. GLP-1 medicines…
A large observational study suggests that GLP-1 receptor agonists may offer protective benefits against fragility fractures in older adults with type 2 diabetes, raising hopes for broader skeletal health effects beyond glucose regulation. A large observational study has added to…
A Bahrain-backed charity has donated insulin pumps to ten children with diabetes, emphasising social solidarity and improving disease management with advanced technology. Ten children with diabetes have received insulin pumps in a Bahrain-backed charity initiative aimed at easing the daily…
Breakthrough T1D announces its 2026-27 run season, leveraging major international races to boost awareness and funding for type 1 diabetes research, including innovative support options like the ‘My Run’ programme. Breakthrough T1D has launched its 2026-27 run season, using a…
While sweet potatoes are carbohydrate-rich, their fibre and nutrient profile can support health for diabetics when prepared and portioned carefully, highlighting the importance of balanced cooking methods and pairing with fat or protein. Sweet potatoes can fit into a diabetes-friendly…
A health initiative in South Africa is breaking language barriers by providing diabetes-friendly dietary guidance through short videos in seven local languages, promoting healthy eating and lifestyle choices for long-term wellbeing. A South African health project is making diabetes-friendly advice…
Researchers at UC San Diego have created CHARM, a prototype smart ring capable of non-invasively tracking glucose, ketones, and other biomarkers from sweat, potentially transforming health monitoring , though regulatory approval is still pending. Researchers at the University of California,…
As digital therapeutics grow in scope and application, regulatory scrutiny is sharpening, emphasising the importance of evidence and clear clinical claims for these software products designed to treat specific conditions. Digital therapeutics are software products designed to do the work…
The emerging drug Tirzepatide, with its dual hormone receptor action, offers promising advances in weight and glucose management, yet concerns around digestive side effects and unregulated online marketing highlight the need for cautious oversight. Tirzepatide has become one of the…
LilyLink has been selected to enhance maternal diabetes support for rural communities in New Jersey through the US federal Rural Health Transformation programme, utilising remote monitoring and specialist guidance to improve outcomes outside urban centres. LilyLink says it has been…
